Abstract Background HIV-infection, tuberculosis and malaria are the big three communicable diseases that plague sub-Saharan Africa. If these occur as co-morbidities they require polypharmacy, which may lead to severe drug–drug-gene interactions variation in adverse drug reactions, but also treatment outcomes. Polymorphisms genes encoding drug-metabolizing enzymes major cause of variations, such...